TriNetX

Cambridge, United States Founded: 2013 • Age: 13 yrs Acquired By The Carlyle Group
Clinical trial management software is provided for researchers and professionals.

About TriNetX

TriNetX is a Healthcare company based in Cambridge (United States) founded in 2013, and was acquired by The Carlyle Group in September 2020. Clinical trial management software is provided for researchers and professionals. TriNetX has raised $53 million across 2 funding rounds from investors including Mitsui & Co, The Carlyle Group and ITOCHU. The company has 95 employees. TriNetX has completed 3 acquisitions, including Advera Health, Custodix and Insite Platform. Its website trinetx.com draws about 144 thousand monthly visits. TriNetX offers products and services including TriNetX LIVE™ and EVIDEX®. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is TriNetX, LLC. Its competitors include Medidata, Verily and Signant Health; 2 of its 3 listed competitors have raised funding.

Company details

TriNetX offers clinical trial management software for researchers and professionals. The company has developed tools like TriNetX Analyze that assist in analyzing clinical trial data, TriNetX Research that gives a comparative analysis of treatment and outcomes, TriNetX Analyze assist in analyzing medical reports for medication conflicts, and more. The TriNetX Network, allows researcherssponsors to analyze patient populations, refine clinical study assumptions, and ultimately locate the best clinical sites and successfully recruit patients to their study. It enables pharmaceutical companies, healthcare providers, and CROs to truly leverage patient data in a way that fosters collaboration and efficiency in clinical research to make a lasting impact on drug development and bring new therapies to market faster.

  • Headquarters Cambridge, United States
  • Employees 95
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website trinetx.com
  • Social LinkedIn X
  • Acquired by The Carlyle Group (Sep 2020)
  • Legal Name Trinetx, Llc
Key Metrics

Products & Services of TriNetX

TriNetX offers a comprehensive portfolio of products and services, including TriNetX LIVE™ and EVIDEX®.

TriNetX LIVE™
Analytics Platform

Platform for querying de-identified patient records and analytics.

EVIDEX®
Pharmacovigilance Platform

Tool for detecting and managing drug safety signals.

Funding Insights of TriNetX

TriNetX has successfully raised a total of $53M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $40 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $53M
  • Total Rounds 2
  • Last Round Series D — $40M
  • First Round $13M

    (Jun 2014)

  • Investors Count 7

All 2 funding rounds of TriNetX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2019$40MSeries D–Merck Global Health Innovation Fund
Jun 2014$13MSeries A––
–
Valuation history

8 investors in total: 8 institutional.

Investors in TriNetX

TriNetX has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Mitsui & Co, The Carlyle Group and ITOCHU.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Corporate-backed venture capital is focused on the life science sector.
merckghifund.comKenilworth, United States
Healthcare ecosystem is supported through investment and innovation by Deerfield.
deerfield.comNew York, United States
f2-ventures.com
Private equity investments are directed toward multiple sectors.
1986carlyle.com
Traditional conglomerate services are provided across multiple sectors by Mitsui.
1947mitsui.comChiyoda City, Japan
techv.co.jp
Diversified trading and procurement solutions are offered across multiple sectors.
1858itochu.co.jpTokyo, Japan
Invests in biotech firms developing life-saving drugs and technologies.
mpmcapital.com
Premium access

Investor details for TriNetX

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of TriNetX

37 people are tracked at TriNetX (21 in leadership, 6 in board & advisors, 10 in team); the tracked headcount is 95.

NameRoleGroup
Steve Kundrot
Chief Operating OfficerLeadership
Kristen Jackson Collins
Senior Vice President, SalesLeadership
Brynna Epperly
HR DirectorLeadership
Michael Sullivan
Executive Director, SalesLeadership
Betty Cosgrove
Sales Director, PharmaLeadership
Jennifer Eagan
VP of PeopleLeadership
Jeffrey Brown
Chief Scientific OfficerLeadership
Anthony Ferretti
Director, Financial Planning And AnalysisLeadership
Mohamed Dimbil
Director Of Data Sciences & AnalyticsLeadership
Jacob Malaluan
Director, Strategic SalesLeadership
Shields Carstarphen
Chief Commercial OfficerLeadership
Mike Murphy
Director Of Sales OperationsLeadership
Scott Clymer
Executive Director, SalesLeadership
Mona Abdi
Director, Business Development (emea)Leadership
Michelle Fleming
Chief Marketing OfficerLeadership
Damian Mangino
Vice President FinanceLeadership
Alexis Pagliarini
Talent Acquisition PartnerLeadership
Karen Tunks
Director, Content & CommunicationsLeadership
Benjamin Baldwin
Senior Director, Channel Partnership Strategy & SalesLeadership
Bill Hutchins
Vice President, Clinical Data PartnershipsLeadership

17 more people are available in the full profile.

Premium access

Complete people profiles for TriNetX

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by TriNetX

TriNetX has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Advera Health, Custodix and Insite Platform.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry
adverahealth.comSanta Rosa, United States2010Jan 2022••••
Provider of clinical data management platform
insiteplatform.comSint Martens Latem, Belgium2015Apr 2019••••
Clinical trial patient recruitment solutions are provided by Custodix.
custodix.com2000Apr 2019••••
Premium access

Complete acquisition details for TriNetX

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of TriNetX

7 dated milestones of TriNetX across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded TriNetX is founded.
  2. Funding First funding round of $13.0M.
  3. Funding Latest funding round, Series D, of $40.0M.
  4. Acquisition Acquires Insite Platform.
  5. Acquisition Acquires Custodix.
  6. Exit Acquired by The Carlyle Group.
  7. Acquisition Acquires Advera Health.

Competitors of TriNetX

TriNetX has 3 listed competitors in our database, 2 of them funded. They include Medidata, Verily and Signant Health.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medidata.com1999New York, United States$41.5M1,677
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
verily.com2015Dallas, United States$2.5B
AI-based solutions for health management are provided.
signanthealth.com2000Plymouth Meeting, United States
Signant Health is engaged in providing clinical trial technology solutions.
Premium access

Detailed competitors of TriNetX

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of TriNetX

The website of TriNetX (trinetx.com) receives about 143.8K visits a month and ranks #128,176 among all websites worldwide, #3,846 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    143.8K

    ▼ 10.8% vs previous month

  • Unique visitors
    31.2K

    per month

  • Global rank
    #128,176

    among all websites

  • Category rank
    #3,846

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with TriNetX. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
flexdatabases.com
100%
#4,665,321View details
iqvia.com
100%
1.2M#45,953View details
jamanetwork.com
92%
#14,192View details
utmb.edu
85%
1.4M#42,559View details
uworld.com
uworld.com
84%
#3,608–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 32 similar websites and full traffic analytics for TriNetX

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 32 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as TriNetX (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Trinetx

Premium access

Complete news archive for TriNetX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about TriNetX

TriNetX was founded in 2013 and raised its 1st funding round 1 year after it was founded.

TriNetX is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

TriNetX is a funded company, having raised a total of $53M across 2 funding rounds to date. The company's 1st funding round was a Series A of $13M, raised on Jun 2014.

TriNetX has 95 employees.

TriNetX offers clinical trial management software for researchers and professionals. The company has developed tools like TriNetX Analyze that assist in analyzing clinical trial data, TriNetX Research that gives a comparative analysis of treatment and outcomes, TriNetX Analyze assist in analyzing medical reports for medication conflicts, and more. The TriNetX Network, allows researcherssponsors to analyze patient populations, refine clinical study assumptions, and ultimately locate the best clinical sites and successfully recruit patients to their study. It enables pharmaceutical companies, healthcare providers, and CROs to truly leverage patient data in a way that fosters collaboration and efficiency in clinical research to make a lasting impact on drug development and bring new therapies to market faster.

TriNetX's top competitors include Medidata, Verily and Signant Health.

TriNetX offers TriNetX LIVE™ and EVIDEX®.

TriNetX has made 3 acquisitions, including Advera Health, Custodix, and Insite Platform.

TriNetX has 8 investors. Key investors include Mitsui & Co, The Carlyle Group, ITOCHU, Merck Global Health Innovation Fund, and ITV.

TriNetX operates through Trinetx, Llc.

Yes. TriNetX was acquired by The Carlyle Group in September 2020.

The website of TriNetX receives about 144 thousand visits a month and ranks #128,176 among all websites worldwide.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available